Filter
3121
Text search:
adverse
health
effects
Featured
Recommendations
340
New Publications
754
Language
Document type
No document type
1636
Studies & Reports
535
Guidelines
534
Manuals
180
Strategic & Response Plan
101
Fact sheets
56
Training Material
45
Situation Updates
13
Infographics
7
Brochures
6
Resource Platforms
5
Videos
2
App
1
Countries / Regions
India
148
Global
136
Kenya
75
Western and Central Europe
72
South Africa
64
Ethiopia
61
Nepal
52
Uganda
51
Nigeria
47
Tanzania
41
Latin America and the Carribbean
40
Africa
39
Sierra Leone
37
Ghana
37
Zambia
35
Malawi
31
Philippines
29
Liberia
28
Myanmar / Burma
28
Bangladesh
27
Rwanda
23
Ukraine
23
South–East Asia Region
21
Zimbabwe
20
Namibia
19
Eastern Europe
19
Syria
18
Cambodia
17
Indonesia
15
East and Southern Africa
14
Asia
14
USA
12
Brazil
12
Guinea
11
South Sudan
11
Botswana
11
Eastern Europe and Central Asia
11
Senegal
10
Germany
10
Eswatini/ Swaziland
10
Congo, Democratic Republic of
9
Mozambique
9
Sudan
9
West and Central Africa
9
Middle East and North Africa
9
Russia
9
Thailand
8
Lesotho
8
Western Pacific Region
8
Burkina Faso
7
Yemen
6
Venezuela
6
Pakistan
5
Colombia
5
Moldova
5
Mali
4
Jordan
4
Afghanistan
4
China
4
Sri Lanka
4
Cameroon
3
Niger
3
Haiti
3
Somalia
3
Lebanon
3
Egypt
3
Madagascar
3
Laos
3
Iraq
2
Gambia
2
Singapore
2
Benin
2
Central African Republic
2
Argentina
2
North Macedonia
2
Ecuador
2
Angola
2
Chile
2
Paraguay
2
Palestine
2
Timor Leste/ East Timor
2
Tajikistan
2
Kyrgyzstan
2
Georgia
2
Vietnam
2
North America
2
Belarus
2
Guinea-Bissau
1
Côte d’Ivoire / Ivory Coast
1
Chad
1
Mauritania
1
Ireland
1
Papua New Guinea
1
Vanuatu
1
Peru
1
Burundi
1
Honduras
1
El Salvador
1
Greece
1
Guatemala
1
Other region
1
Fiji
1
Solomon Islands
1
Bhutan
1
Poland
1
Albania
1
Djibouti
1
Canada
1
Romania
1
Lithuania
1
Iran
1
Kazakhstan
1
Turkmenistan
1
United Kingdom
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
949
Clinical Guidelines
346
Public Health
182
Women & Child Health
182
Key Resources
171
Capacity Building
46
Pharmacy & Technologies
29
Toolboxes
Mental Health
349
COVID-19
244
TB
200
HIV
193
Planetary Health
181
Pharmacy
102
NTDs
101
NCDs
95
AMR
82
Caregiver
80
Ebola & Marburg
62
Conflict
62
Global Health Education
60
Refugee
53
Disability
48
Rapid Response
45
Malaria
44
Specific Hazards
37
Natural Hazards
35
2.0 Rapid Response
29
Zika
22
Health Financing Toolbox
20
Polio
14
Cholera
10
Social Ethics
5
Typhoon
2
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons
...
In May the Sixty-sixth World Health Assembly adopted resolution WHA66.12 (1) on 17 neglected tropical diseases (NTDs). Among other measures, the resolution urges Member States to:
• ensure country ownership of prevention, control, elimination an
...
4th edition. This is fourth edition of Treatment of tuberculosis: guidelines, adhering fully to the new WHO process for evidence-based guidelines. Several important recommendations are being promoted in this new edition
In the Region of the Americas, between epidemiological week (EW) 1 and EW 52 of 2018, a total of 560,586 cases of dengue were reported (incidence rate of 57.3 cases per 100,000 population), including 336 deaths. Of the total cases, 209,192 (37.3%) were laboratoryconfirmed and 3,535 (0.63%) were clas
...
The WHO Living guideline: Drugs to prevent COVID-19 contains the Organization’s most up-to-date recommendations for the use of drugs to prevent COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform.
Guidelines
...
Guidelines for treatment of drug-susceptible tuberculosis and patient care
Uptsate 2017
The publication of the Second Edition of the Emergency Drug Guidelines represents the culmination of the efforts of the National Drugs and Therapeutics Committee (NDTC) to publish clinical drug guidelines for common diseases seen in Fiji. These guidelines are targeted for
...
This field guide is designed for use by FHI 360 staff and partner organizations responsible for ensuring quality clinical services, at both facility and non-facility levels. The guide provides general information on how to organize, implement and follow up on quality assurance/quality improvement cl
...
This summary brief highlights key messages from the updated World Health Organization’s recommendation on tranexamic acid (TXA) for the treatment of postpartum haemorrhage (PPH), including policy and program implications for translating the TXA re
...
Session outline
•Introduction to depression
•Assessment of depression
•Management of depression
•Follow-up
•Review
As a deliverable of the G20 Health and Finance Ministers' Meeting on June 28, 2019, ministers confirmed their commitment to this "G20 Shared Understanding."
10 points from field experience
Standard Treatment Guideline
Q 1: Are antidepressants (Tricyclic Antidepressants (TCA) and Selective Serotonin Reuptake Inhibitors (SSRI)) better (more
effective than/as safe as) than treatment as usual (placebo) in adults with depressive episode/disorder?